baber/WOPTO huggingface dataset:
Patent AU-2013319971-A1 (AU)
Title: Monitoring of people and objects
Inventor: VALLEJO VEIGA IVAN
IPC: G01S7/48
Filed: 2013-09-12
Abstract: A method and apparatus for monitoring the movement and activity of targets is provided. The method comprises the steps of initially detecting electromagnetic (EM) radiation reflected by the target and recording spectral information relating to it and detecting EM radiation reflected by a target at a later time and again recording spectral information relating to it. The spectral information relating to the initially detected and later detected targets is then compared, so as to establish whether the initially detected and later detected targets are the same.
Patent AU-2013320251-A1 (AU)
Title: Novel IL-17A binding molecules and medical uses thereof
Inventor: SILACCI MELKKO MICHELA
IPC: A61K38/16
Filed: 2013-09-19
Abstract: The present invention relates to a polypeptide inhibiting the activity of glycosylated IL-17A, wherein the polypeptide comprises or consists of an amino acid sequence selected from the group consisting of: (a) GVTLFVALYDY(X
Patent AU-2013326816-A1 (AU)
Title: Currency operated tire inflation and repair apparatus and methods
Inventor: PAASCH ROBERT W
IPC: B60S5/04
Filed: 2013-10-07
Abstract: The present disclosure provides tire repair assemblies that can include : a tire sealant tank; an air assembly coupled to the tire sealant tank; a valve configured to control flu id communication between the tank and the air assembly; and a currency operating assembly configured to control the valve. Methods for repairing tires are also provided with the methods including providing tire sealant to a tire from a tire repair assembly upon depositing currency in the tire repair assembly. A stand alone currency operated tire repair assemblies are also provided with the assemblies including : a tire sealant tank; an air compressor operatively coupled to the tank; a valve operatively aligned between the tank and the air compressor; a flow meter operatively aligned between the tank and the air compressor; and computer processing circuitry operatively coupled to the air compressor, the valve, and the flow meter.
Patent AU-2013336781-A1 (AU)
Title: Process for the purification of abiraterone acetate
Inventor: ALPEGIANI MARCO
IPC: C07J43/00
Filed: 2013-10-21
Abstract: The invention relates to a process for the purification of crude abiraterone acetate by treatment with polymer resins in aqueous solvent. The purified product is recovered by simple concentration and filtration.
Patent AU-2013360268-A1 (AU)
Title: Systems and methods for integrating storage usage information
Inventor: WICKS DAVID
IPC: G06F11/32
Filed: 2013-09-10
Abstract: Systems and methods for integrating storage usage information are disclosed. In some implementations, a method includes, at a computer system, displaying, in a first pane, a portion of a hierarchical data structure having a plurality of structural elements. A user selection of a structural element, which includes a plurality of sub-elements, is obtained. In response to the user selection of the structural element: a first grid including: (a) user identifiers, (b) storage usage information corresponding to the user identifiers, in accordance with predefined time ranges, and (c) total storage usage information corresponding to the user identifiers is displayed in a second pane. Further, a second grid including: (a) a first ranked plurality of sub-elements and (b) storage usage information corresponding to the first ranked plurality of sub-elements is also displayed in a third pane.
Patent WO-2014117205-A1 (WO)
Title: Method and system for clinical measurement of lung health
Inventor: FOURAS ANDREAS
IPC: A61B6/02
Filed: 2014-01-24
Abstract: A method for investigating a subject lung, the method comprising the steps of (i) applying resistance to respiration of the lung, (ii) carrying out a functional measurement of the lung and (iii) correlating the resistance applied with the functional measurement to obtain information regarding lung function.
Patent AU-2014202979-A1 (AU)
Title: Prostaglandin E2 binding proteins and uses thereof
Inventor: Zhu rong-rong
IPC: A61K39/395
Filed: 2014-06-02
Abstract: PROSTAGLANDIN E2 BINDING PROTEINS AND USES THEREOF Abstract The present invention encompasses prostaglandin E2 (PGE 2) binding proteins. The invention relates to antibodies that are wild-type, chimeric, CDR grafted and humanized. Preferred antibodies have high affinity for prostaglandin E2 and neutralize prostaglandin E2 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody, or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antigen-binding portions, of the invention are useful for detecting prostaglandin E2 and for inhibiting prostaglandin E2 activity, e.g., in a human subject suffering from a disorder in which prostaglandin E2 activity is detrimental.
Patent AU-2014203122-A1 (AU)
Title: Anti-obesity potential of calebin a
Inventor: MAJEED MUHAMMED
IPC: A23L33/00
Filed: 2014-06-10
Abstract: The present invention discloses the potential of Calebin A in inhibiting adipogenesis and applications thereof in obesity management. The present invention elucidates the potential of Calebin A to favorably modulate biochemical markers associated with obesity. Notable 5 biomodulatory properties of Calebin A include inhibiting leptin production, increasing adiponectin expression and inhibiting local (adipocyte) and systemic inflammation caused by pro-inflammatory cytokines Tumor Necrosis Factor (TNF-u), Interleukin-6 (IL-6) and Interleukin- 1 (IL-1 ).
Patent AU-2014209994-A1 (AU)
Title: TNF-alpha antigen-binding proteins
Inventor: CROTTS GEORGE
IPC: C07K16/24
Filed: 2014-01-22
Abstract: The present invention provides liquid formulations comprising antigen binding proteins which bind specifically to TNF-alpha and histidine buffer. For example novel variants of anti-TNF antibodies such as adalimumab which show increased binding to the FcRn receptor or increased half life compared to adalimumab. Also provided are compositions comprising the antigen binding proteins and uses of such compositions in treatment of disorders and disease.
Patent AU-2014218388-A1 (AU)
Title: Adapter direct drive twist-lock retention mechanism
Inventor: RICHARD PAUL D
IPC: A61B17/03
Filed: 2014-08-27
Abstract: ADAPTER DIRECT DRIVE TWIST-LOCK RETENTION MECHANISM A surgical device adapter (200) for coupling an end effector (300) to a handle assembly (100) is disclosed. The surgical device adapter (200) includes: a housing (232) including a proximal end couplable to a distal end of a handle assembly (100); and a drive coupling assembly (210) and selectively couplable to the handle assembly (100), the drive coupling assembly (210) including a tubular clamping member (250) having at least one flexible member (254), the tubular clamping member (250) movable from a proximal position in which the at least one flexible member (254) is disengaged from the distal end of the handle assembly (100) to a distal position in which the at least one flexible member (254) is engaged to the distal end of the handle assembly (100). Fig. 4 220 222 218 200 232 B 242 252 3 252 250 258 257 A Fig. 6
Patent AU-2014218455-A1 (AU)
Title: Ferric Citrate Dosage Forms
Inventor: LE HENRY TRONG
IPC: A61K31/295
Filed: 2014-08-29
Abstract: The disclosure relates to ferric citrate tablets and dosage forms. - 37 - WO 2011/011541 PCT/US2010/042788 HARDNESS VS. COMPRESSION FORCE $ 15.0 C/3 Lu -V- EXAMPLE 1 -+- EXAMPLE 2 --o- EXAMPLE 4 --A- EXAMPLE 5 0.0- i i i I 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 COMPRESSION FORCE
Patent AU-2014225444-A1 (AU)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12P19/02
Filed: 2014-03-07
Abstract: Biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) is processed to produce useful intermediates and products, such as energy, fuels, foods or materials. Two or more sugars can be produced and these can be further processed and purified. For example, a mixture of the two or more sugars can be selectively fermented to leave one or more sugars in the mixture along with a product. The unfermented sugar may be fermented with a different fermenting system and produce a second product.
Patent AU-2014256849-A1 (AU)
Title: Pressure sensing medical device system for remote patient monitoring and prevention of pressure ulcers
Inventor: MAY KEENAN
IPC: A61B5/103
Filed: 2014-04-23
Abstract: A patient movement monitoring system comprising sensing hardware (100) which can be in the form of a sheet or planar member that is placed under a patient who may be susceptible to pressure ulcers due to lack of movement. The sensing hardware can comprise two or more energy harvesting devices (102) with each energy harvesting device (102) being configured to output a current in response to detected patient movement. Each energy harvesting device (102) can comprise a piezoelectric device. The system can also comprise a wirelesss transmitter (105) that can be powered by at least one of the currents and on receipt of said currents transmits at least one data packet representative of the detected movement, a network that communicates the respective currents from the energy harvesting devices to the wireless transmitter (105) and a remote receiving device (106) or computer running sensing software (108) that processes the at least one data packet and provides an output of said data for analysis.
Patent AU-2014262182-A1 (AU)
Title: IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
Inventor: BROOKS DAVID
IPC: C12P21/08
Filed: 2014-11-11
Abstract: IGF-1 R SPECIFIC ANTIBODIES USEFUL IN THE DETECTION AND DIAGNOSIS OF CELLULAR PROLIFERATIVE DISORDERS Abstract The present invention relates to mammalian antibodies, designated 12B1 and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), preferably human IGF-IR. Also included are chimeric, bispecific, derivatized, single chain antibodies derived from the antibodies disclosed herein. Nucleic acid molecules encoding the mammalian antibodies as well as methods of use thereof are also disclosed. Also included are pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for treatment and diagnosis of pathological hyperproliferative oncogenic disorders associated with expression of 1 Gf-1 R. (4471111 11-M(;-H
Patent AU-2014310353-A1 (AU)
Title: Metal pallet with assemblable components
Inventor: PISANO ROBERTO
IPC: B65D19/00
Filed: 2014-08-19
Abstract: An assemblable metal pallet with at least two plinths (18) each provided with a cut-out and with a loading platform (20) characterized by consisting of a plurality of components (4, 6, 8, 10, 60, 62, 64, 66) all obtained from a single piece of basic metal profile (2, 2'), the shape of which is symmetrical about the longitudinal central plane and is provided with at least one longitudinal rib (12) of rectangular cross-section and of constant height extending from one and the same part with respect to a base plane (14), and with two outer lateral webs (16) having their edge bent inwards and at least partly coplanar with the top (17) of said rib (12), said components comprising a first component (4, 60) consisting of a piece of basic profile (2) bent to C-shape with the aperture facing upwards, a second component (6, 62) consisting of a piece of the same basic profile (2) bent to inverted U-shape, a further component (8, 64, 68) formed from a piece of the same basic profile (2), and constituting a crosspiece for connecting together said plinths (18).
Patent AU-2014315605-A1 (AU)
Title: Valve
Inventor: WEBBER ANDREW
IPC: E21B34/06
Filed: 2014-08-01
Abstract: Disclosed herein is a valve. The valve includes a first member having a first port therethrough, a second member in operable communication with the first member having a sealing surface thereon on an inner radial surface of the second member and a second port therethrough that is movable relative to the first member. The valve also has a seal sealingly engaged with the first member and slidably sealingly engagable with the second member, and a support member movably disposed relative to the first member and the second member. The support member has a support surface dimensioned similarly to the sealing surface, and is movable with the second member relative to the first member so that upon such movement the seal is continuously supported by at least one of the sealing surface and the support surface.
Patent AU-2014316839-A1 (AU)
Title: Radiopaque polymers
Inventor: HOHN STEPHANE
IPC: A61K49/04
Filed: 2014-09-05
Abstract: Radiopaque hydrogels, in particular radiopaque hydrogel microspheres, comprising a polymer having 1,2-diol or 1,3-diol groups acetalised with radiopaque species.
Patent AU-2014324068-A1 (AU)
Title: Endotracheal tube and method of use
Inventor: DHARA SASANKA SEKHAR
IPC: A61M16/04
Filed: 2014-08-05
Abstract: The present invention provides anendotracheal tubewith a tip suitable for traversing the laryngeal inlet and a guidingchannelwhich allows wire guided intubation, a method and a kit relating to the same.
Patent AU-2014329531-A1 (AU)
Title: Substituted berbines and their synthesis
Inventor: GROTE CHRISTOPHER W
IPC: C07D455/03
Filed: 2014-10-02
Abstract: The present invention provides substituted berbines, processes for the synthesis of substituted berbine compounds preferably through a Bischler-Napieralski cyclization followed by reduction, as well as intermediates used in the synthesis of substituted berbine compounds. The amide precursor for the Bischler-Napieralski reaction could be obtained treating the free amine with acid halides, formate sources or aldehydes. Also provided are methods for using the substituted berbines to inhibit cancer cell growth.
Patent AU-2014336402-A1 (AU)
Title: Stabilisation of enzymes in aqueous systems containing surfactants
Inventor: HELLMUTH HENDRIK
IPC: C11D3/386
Filed: 2014-10-09
Abstract: The invention relates to the strengthening of the performance of enzymes in detergents or cleaning agents which contain water and surfactants, or at least to the conservation of same after storage. This is substantially achieved with the use of polymers that can be obtained by polymerising N-vinyl pyrrolidone with a co-monomer selected from the group comprising: N-vinyl caprolactam, N-vinyl piperidone, N-vinyl succinimide, N-vinyl glutarimide, N-vinylacetamide, N-alkyl-N-vinylacetamide, N-vinylformamide, N-alkyl-N-vinylformamide, dialkyl acrylamide, and mixtures of at least two of these.
Patent AU-2014345562-A1 (AU)
Title: Crystalline forms of S-acetyl glutathione, their preparations and uses in pharmaceutical and nutraceutical formulations
Inventor: BIANCHI DAVIDE
IPC: C07K5/02
Filed: 2014-11-06
Abstract: Disclosed are two crystalline forms of S-acetyl glutathione (SAG) called Form A and Form B, obtained by crystallisation of SAG from mixtures of water-acetone, water-ethanol or water-methanol, preferably acetone, under controlled conditions. The crystalline forms are characterised by X-ray powerder diffrraction, IR spectrum and DSC. Forms A and B can be advantageously used as ingredients of pharmaceutical or nutraceutical formulations.
Patent AU-2014380149-A1 (AU)
Title: Gastric calibration tube
Inventor: ROKDE RAJAT R
IPC: A61F2/04
Filed: 2014-11-10
Abstract: A gastric calibration tube includes a flexible elongate member, a pushing member, and a balloon member. The flexible elongate member has a proximal end portion, a distal end portion, and an outer surface that extends between the proximal and distal end portions. The outer surface defines a side opening. The flexible elongate member defines a lumen that is in communication with the side opening. The pushing member has a proximal portion and a distal portion. The distal portion is advanceable through the lumen of the flexible elongate member and out of the side opening of the flexible elongate member. The balloon member is secured to one or both of the flexible elongate member and the pushing member. The balloon member is inflatable to fix the gastric calibration tube within a patients stomach.
Patent AU-2014410945-A1 (AU)
Title: Suctioning device for large artificial water bodies
Inventor: FISCHMANN TORRES FERNANDO BENJAMIN
IPC: A47L9/06
Filed: 2014-11-12
Abstract: The present invention relates to a flexible suctioning device for suctioning floes from the bottom of large artificial water bodies with surfaces larger than 10,000 m and with bottoms covered with plastic liners that do not have centralized filtration systems, and that is able to clean a bottom surface of large artificial water bodies at a surface cleaning rate of 325,000 ft
Patent WO-2016070241-A1 (WO)
Inventor: STEVENSON GRAEME IRVINE
IPC: A61K31/53
Filed: 2015-10-30
Abstract: La présente invention concerne généralement des composés de triazine, des procédés de préparation de composés de triazine et des compositions comprenant des composés de triazine. La présente invention concerne également des composés de triazine et leur utilisation en tant qu'intermédiaires dans des procédés de préparation de composés de triazine cible, permettant l'accès à des agents anticancéreux à base de triazine.
Patent AU-2015201558-A1 (AU)
Title: Subsea drilling with casing
Inventor: TREVINO JOSE A
IPC: E21B7/20
Filed: 2015-03-26
Abstract: SUBSEA DRILLING WITH CASING A tubular conveying apparatus (360) comprising a tubular body (362) having a plurality of windows (363) and one or more gripping members (364) radially movable between an engaged position and a disengaged position in the windows (363). A mandrel (340) disposed in the tubular body (362) and selectively movable from a first position, wherein the gripping member (364) is in the engaged position, to a second position, to allow the gripping member (364) to move to the disengaged position.
Patent AU-2015204361-A1 (AU)
Title: Method and System for Optimal Reserving, Pricing and Allocation of a Set of Debt Instruments to be Offered
Inventor: AVERY CALEB
IPC: G06Q40/04
Filed: 2015-07-16
Abstract: A method and system for the determination of optimal pricing and allocation of securities in an open, competitive environment. The method and system may also be used in developing premarkets of other items that are difficult to price and allocate in a competitive manner, such as the underwriting/ securitization of contracts for property; future revenue/earning streams from an asset and/or group of assets; underwritten insurance portfolios, intellectual property and other goods and services. The system of price optimization and allocation is accomplished by interactive feedback of information using a display and including competitive participation of individual members of the public (and/or their agents) or institutional buyers over a data network e.g., the Internet, uncovering the nature and identification of demand in a self-organizing fashion. Demand emerges through participants' interaction with the system and with each other, via a graphically-supported, interactive reservation process. Documents - 16/7/15 Participant Suitability Implementer Issuer Group Workflow / Operator /Seller Manager Web Services./ APIs Database Reservation Rights Calculator Bidstream Database Oversubscription Engine 0 OvlerlayEngine 9-o iMessaging Engine Document Manager
Patent AU-2015205941-A1 (AU)
Title: Communication services
Inventor: ALLA RAJESH
IPC: G06Q20/00
Filed: 2015-07-24
Abstract: An advanced intelligent communication system that provides subscriber-requested, advanced communication services through existing communication switches even in those circumstances in which the hardware communication switch is not configured to provide such communication services. The system supports the use of personal identification number access cards for use in fixed and mobile markets from any communication device located anywhere in the world and provides flexible call processing and switching services that deliver enhanced computer telephony capabilities utilizing standard communication equipment and operating systems.
Patent AU-2015226160-A1 (AU)
Title: Implant surface composition
Inventor: HALL JAN
IPC: A61K6/838
Filed: 2015-03-05
Abstract: An implant structure or parts thereof having a surface composition obtainable through an anodic oxidation process is disclosed. The surface composition comprising titanium oxide in the anatase crystalline phase and at least 90% of the pores have an orifice with a mean inside diagonal distance of less than 0,1 μm. It is also disclosed an implant system comprising said surface composition and a method of obtaining said surface.
Patent AU-2015227424-A1 (AU)
Title: Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
Inventor: MAEDA ATSUHIKO
IPC: G01N33/50
Filed: 2015-09-16
Abstract: ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY It is found that a molecule of an antibody which exhibits a weaker antigen-binding activity at a p11 value in an early endosome compared with that at a p11 value in a plasma can bind to two or more antigen molecules, and it is also found that the antibody has a long half-life in a plasma and is improved in the period during which the antibody can bind to an antigen.
Patent AU-2015230363-A1 (AU)
Title: Oxygen scavenging composition for plastic material
Inventor: FAVA FLAVIO
IPC: C08K5/3435
Filed: 2015-03-05
Abstract: The invention relates to the use of an additive as oxygen scavenger in a plastic material, wherein (a) the plastic material is a polyester, a polyolefin, a polyolefin copolymer or a polystyrene, and the additive (b) is a light stabilizer and optionally a transition metal compound.
Patent AU-2015241514-A1 (AU)
Title: Electrospun biocompatible fiber compositions
Inventor: JOHNSON JED
IPC: A61L17/08
Filed: 2015-02-20
Abstract: A composition comprising a plurality of electrospun fiber fragments comprising at least one polymer, a plurality of electrospun fiber fragment clusters comprising at least one polymer, and, optionally, a carrier medium, is disclosed. Also disclosed is a kit comprising a first component of a plurality of electrospun fiber fragments, and a second component of a carrier medium. Also disclosed is a composition comprising a plurality of micronized electrospun fiber fragments, a carrier medium, and, optionally, a plurality of cells. Also disclosed is a biocompatible textile comprising a plurality of micronized electrospun fiber fragments. Also disclosed is a biocompatible suture comprising at least one electrospun fiber. Also disclosed is a method for making a biocompatible suture, comprising electrospinning a polymer solution onto a receiving surface, forming one or more non-overlapping nanofiber threads, removing the nanofiber threads from the receiving surface, and cutting the nanofiber threads into one or more biocompatible sutures.
Patent AU-2015245416-A1 (AU)
Title: Novel combination between 8-cyclopropyl-3-[2-(3-fluorophenyl) ethyl]-7,8-dihydro-3H-[1,3]oxazino[6,5-g][1,2,3]benzotriazine-4,9-dione and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing same
Inventor: BRETIN SYLVIE
IPC: A61K45/06
Filed: 2015-04-03
Abstract: Combination between 8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8- dihydro-3H-[l,3] oxazino[6,5-g][l,2,3]benzotriazine-4,9-dione of formula (I) or an addition salt thereof with a pharmaceutically acceptable acid or base, and an acetylcholinesterase inhibitor.